Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

7 treatments under study, led by Rfablation

Research Leaders

7 sponsors active, led by Deutsches Herzzentrum Muenchen

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 6 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (3)
Phase 4 (2)

Trial Status

Completed3
Recruiting2
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (6)

Research Network

Common Treatments

  • Rfablation2
  • Nasopharyngeal Swab Insertion1
  • High Resolution Cartography1
  • Cryo Ablation1
  • Conventional Slow Pathway Ablation1

Active Sponsors

  • Deutsches Herzzentrum Muenchen2
  • CryoCath Technologies Inc.1
  • University Hospital, Toulouse1
  • Marmara University Pendik Training and Research Hospital1
  • University of Bergen1

Top Investigators

Related Conditions

  • Supraventricular Tachycardia2
  • Vagal Maneuver1
  • Supraventricular Tachycardia Svt1
  • Paroxysmal Supraventricular Tachycardia1
  • Radiofrequency Ablation1

Activity Timeline